Orthopedic Cartilage Repair Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Osteochondral Allograft Market, Meniscal Allograft Market, and 2 more

  • Year: 2025
  • Scope: 10 Years
  • Region: Global
  • Published Date: 01/24/2025
  • Type: MedCore

Product Description

The global orthopedic cartilage repair market was valued at $405 million in 2024. This is expected to increase over the forecast period at a CAGR of 9.2% to reach $750 million.

The full report suite on the global market for orthopedic cartilage repair includes osteochondral allografts, meniscal allografts, autologous chondrocytes and osteochondral autograft.

This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031, and Historical Data to 2021
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

GLOBAL ORTHPEDIC CARTILAGE REPAIR MARKET INSIGHTS

Global Orthopedic Cartilage Repair Market GrowthOne of the main market limiters remains to be the high cost of the procedure. The high cost of the procedure is out of the budgetary range of many potential patients, even for some with private insurance. This cost is not expected to decline significantly over the forecast period and will continue to limit the number of units sold.

GLOBAL ORTHPEDIC CARTILAGE REPAIR MARKET SHARE INSIGHTS

Global Orthopedic Cartilage Repair Market Leaders

  • Vericel was the leader in the cartilage repair market due to its offering of MACI®, an autologous cartilage repair therapy for knee defects. The treatment involves expanding a patient’s own cartilage cells on a collagen membrane for implantation. In August 2024, the FDA approved an arthroscopic delivery method, allowing for less invasive procedures and faster recovery.
  • Octane Medical Group, the second-leading company in the cartilage repair market, expanded its regenerative medicine portfolio by acquiring B. Braun’s global orthobiologics business, including TETEC AG and Aesculap Biologics. Through this acquisition, Octane Medical strengthened its position by offering NOVOCART® 3D, a matrix-associated autologous chondrocyte implantation (ACI) system using a collagen scaffold for knee cartilage repair, and NOVOCART® Inject, an injectable hydrogel-based cartilage repair solution. These additions enhance Octane’s capabilities in advanced orthobiologic treatments, further solidifying its market presence.
  • Arthrex was the third-leading competitor in the cartilage repair market in 2024. The company provides various cartilage repair solutions, including Allograft OATS®, Autograft OATS®, BioCartilage® and Cartiform®, which are used for resurfacing osteochondral defects. The PowerPick system facilitates microdrilling for microfracture procedures, and the joint preservation algorithm offers treatment options for different defect sizes. These products are designed to support joint preservation and cartilage repair.

GLOBAL ORTHPEDIC CARTILAGE REPAIR MARKET SEGMENTATION SUMMARY

  • Osteochondral Allograft Market
  • Meniscal Allograft Market
  • Autologous Chondrocyte Implantation Market
  • Osteochondral Autograft Market

RESEARCH SCOPE SUMMARY

Report Attribute Details
Regions North America(Canada, United States)
Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam)
Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year 2024
Forecast 2025-2031
Historical Data 2021-2023
Quantitative Coverage Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

 

FREE Sample Report

8.1 Executive Summary
8.1.1 Global Orthopedic Cartilage Repair Market Overview
8.1.2 Regions Included
8.2 Introduction
8.2.1 Anatomy
8.2.2 Methods for Cartilage Repair
8.2.2.1 Osteochondral Allograft Transfer
8.2.2.2 Autologous Chondrocyte Implantation
8.2.2.3 Meniscal Allograft Transplantation
8.2.2.4 Osteochondral Autograft
8.2.2.5 Microfracture
8.2.2.6 Microfracture Adjunct
8.2.2.7 Osteoarticular Autograft Transfer System
8.2.2.8 Particulated Juvenile Allograft
8.3 Procedure Numbers
8.3.1 Total Orthopedic Cartilage Repair Procedures
8.3.2 Osteochondral Allograft Procedures
8.3.3 Meniscal Allograft Procedures
8.3.4 Autologous Chondrocyte Implantation Procedures
8.3.5 Osteochondral Autograft Procedures
8.4 Market Overview
8.4.1 By Segment
8.4.2 By Region
8.5 Market Analysis and Forecast
8.5.1 Total Orthopedic Cartilage Repair Market
8.5.2 Osteochondral Allograft Market
8.5.3 Meniscal Allograft Market
8.5.4 Autologous Chondrocyte Implantation Market
8.5.5 Osteochondral Autograft Market
8.6 Drivers and Limiters
8.6.1 Market Drivers
8.6.2 Market Limiters
8.7 Competitive Market Share Analysis
·         AbbVie ·         LCA Pharma
·         Acumed ·         LifeLink Tissue Bank
·         AlloSource ·         LifeNet Health
·         Alphatec Spine ·         Meda Pharma
·         Anika Therapeutics ·         Medtronic
·         Arthrex ·         MTF
·         B. Braun Melsungen ·         Novabone
·         Baxter ·         Nuo Therapeutics
·         Berkeley Advanced Biomaterials ·         Octane Medical
·         Biocell ·         Orthocell Ltd.
·         Biocomposites ·         OrthogenRx
·         Biogennix ·         Orthofix
·         Bioiberica ·         Osteogenics
·         Biomatlante ·         OsteoMed
·         Biotissue Technologies ·         Paragon 28
·         Bioventus ·         Plasmaconcept
·         Bonalive ·         PromoCell
·         Celling Biosciences ·         Rebone Biomaterials
·         Cerapedics ·         Recordati
·         Cingal ·         Regenexx
·         Croma-Pharma ·         Regenity Biosciences
·         CO.DON GmbH ·         RTI Surgical
·         CONMED ·         Sanofi
·         Curasan ·         Sartorius CellGenix GmbH
·         DCI Donor Services ·         Seikagaku
·         DePuy Synthes ·         Smith & Nephew
·         Documedica ·         Solvita
·         Elutia Inc. ·         Spinal Elements
·         Exactech ·         Stella Pharmaceuticals
·         Ferring Pharmaceuticals ·         Stryker
·         Fidia ·         Takara Bio
·         Finceramica ·         Tedec-Meiji
·         Geistlich ·         Terumo
·         Globus Medical/NuVasive ·         Teva Pharmaceutical
·         Hanmi Pharmaceutical ·         ThermoGenesis
·         Healiva ·         TRB Chemedica
·         IBSA Pharma ·         Viatris
·         Integra LifeSciences ·         Vericel
·         Isto Biologics ·         Vivex
·         Kolon Tissuegene ·         Xtant Medical
·         Kuros ·         Zimmer Biomet
Chart 8‑1: Orthopedic Cartilage Repair Market, Global, 2024 & 2031
Chart 8‑2: Orthopedic Cartilage Repair Procedures, Global, 2024
Chart 8‑3: Orthopedic Cartilage Repair Procedures by Segment, Global, 2021 – 2031
Chart 8‑4: Orthopedic Cartilage Repair Device Market by Segment, Global, 2021 – 2031
Chart 8‑5: Orthopedic Cartilage Repair Device Market by Region, Global, 2021 – 2031
Chart 8‑6: Leading Competitors, Cartilage Repair Market, Global, 2024
Figure 8‑1: Orthopedic Cartilage Repair Regions Covered, Global (1 of 2)
Figure 8‑2: Orthopedic Cartilage Repair Regions Covered, Global (2 of 2)
Figure 8‑3: Orthopedic Cartilage Repair Procedures by Segment, Global, 2021 – 2031
Figure 8‑4: Orthopedic Cartilage Repair Procedures by Region, Global, 2021 – 2031
Figure 8‑5: Osteochondral Allograft Procedures by Region, Global, 2021 – 2031
Figure 8‑6: Meniscal Allograft Procedures by Region, Global, 2021 – 2031
Figure 8‑7: Autologous Chondrocyte Implantation Procedures by Region, Global, 2021 – 2031
Figure 8‑8: Osteochondral Autograft Procedures by Region, Global, 2021 – 2031
Figure 8‑9: Orthopedic Cartilage Repair Device Market by Segment, Global, 2021 – 2031 (US$M)
Figure 8‑10: Orthopedic Cartilage Repair Device Market by Region, Global, 2021 – 2031 (US$M)
Figure 8‑11: Orthopedic Cartilage Repair Market, Global, 2021 – 2031
Figure 8‑12: Units Sold by Region, Orthopedic Cartilage Repair Market, Global, 2021 – 2031
Figure 8‑13: Average Selling Price by Region, Orthopedic Cartilage Repair Market, Global, 2021 – 2031 (US$)
Figure 8‑14: Market Value by Region, Orthopedic Cartilage Repair Market, Global, 2021 – 2031 (US$M)
Figure 8‑15: Osteochondral Allograft Market, Global, 2021 – 2031
Figure 8‑16: Units Sold by Region, Osteochondral Allograft Market, Global, 2021 – 2031
Figure 8‑17: Average Selling Price by Region, Osteochondral Allograft Market, Global, 2021 – 2031 (US$)
Figure 8‑18: Market Value by Region, Osteochondral Allograft Market, Global, 2021 – 2031 (US$M)
Figure 8‑19: Meniscal Allograft Market, Global, 2021 – 2031
Figure 8‑20: Units Sold by Region, Meniscal Allograft Market, Global, 2021 – 2031
Figure 8‑21: Average Selling Price by Region, Meniscal Allograft Market, Global, 2021 – 2031 (US$)
Figure 8‑22: Market Value by Region, Meniscal Allograft Market, Global, 2021 – 2031 (US$M)
Figure 8‑23: Autologous Chondrocyte Implantation Market, Global, 2021– 2031
Figure 8‑24: Units Sold by Region, Autologous Chondrocyte Implantation Market, Global, 2021 – 2031
Figure 8‑25: Average Selling Price by Region, Autologous Chondrocyte Implantation Market, Global, 2021 – 2031 (US$)
Figure 8‑26: Market Value by Region, Autologous Chondrocyte Implantation Market, Global, 2021 – 2031 (US$M)
Figure 8‑27: Osteochondral Autograft Market, Global, 2021 – 2031
Figure 8‑28: Units Sold by Region, Osteochondral Autograft Market, Global, 2021 – 2031
Figure 8‑29: Average Selling Price by Region, Osteochondral Autograft Market, Global, 2021 – 2031 (US$)
Figure 8‑30: Market Value by Region, Osteochondral Autograft Market, Global, 2021 – 2031 (US$M)
Figure 8‑31: Leading Competitors, Cartilage Repair Market, Global, 2024

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

  • 2025
  • 10 Years
  • Global
  • 01/24/2025
  • MedCore
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library